Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments. | Biomolecules | 2024 | 39062500 | PubTator, text mining | PubMed |
| Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein. | Biomedicines | 2024 | 39062146 | PubTator, text mining | PubMed |
| Differentially expressed heterogeneous overdispersion genes testing for count data. | PLoS One | 2024 | 39018275 | PubTator, text mining | PubMed |
| Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway. | Int J Mol Sci | 2024 | 39000112 | PubTator, text mining | PubMed |
| How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia. | Hematol Oncol | 2024 | 38949887 | PubTator, text mining | PubMed |
| Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide-Drug Conjugates for Targeted Cancer Therapy. | J Med Chem | 2024 | 38943600 | PubTator, text mining | PubMed |
| Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts. | Mol Ther Oncol | 2024 | 38933492 | PubTator, text mining | PubMed |
| Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment. | J Med Chem | 2024 | 38913699 | PubTator, text mining | PubMed |
| Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. | Mol Cancer Res | 2024 | 38912907 | PubTator, text mining | PubMed |
| ROR1-AS1: A Meaningful Long Noncoding RNA in Oncogenesis. | Mini Rev Med Chem | 2024 | 38859780 | PubTator, text mining | PubMed |
| Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival. | Front Immunol | 2024 | 38846943 | PubTator, text mining | PubMed |
| Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers. | World J Clin Oncol | 2024 | 38835843 | PubTator, text mining | PubMed |
| Heterogeneous Profile of ROR1 Protein Expression across Tumor Types. | Cancers (Basel) | 2024 | 38791952 | PubTator, text mining | PubMed |
| Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis. | Cell Signal | 2024 | 38729321 | PubTator, text mining | PubMed |
| WNT5B drives osteosarcoma stemness, chemoresistance and metastasis. | Clin Transl Med | 2024 | 38689429 | PubTator, text mining | PubMed |
| Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer. | Int Immunopharmacol | 2024 | 38678671 | PubTator, text mining | PubMed |
| Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions. | MAbs | 2024 | 38666503 | PubTator, text mining | PubMed |
| Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1. | J Immunother Cancer | 2024 | 38609317 | PubTator, text mining | PubMed |
| Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. | Front Cell Dev Biol | 2024 | 38601081 | PubTator, text mining | PubMed |
| Role of the Ror family receptors in Wnt5a signaling. | In Vitro Cell Dev Biol Anim | 2024 | 38587578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=9